Global Bioinformatics Software Market Insights and Forecast to 2028

Bioinformatics Software Market

Bioinformatics is a branch of science that uses technology to collect vital information pertaining to the bioengineering, biology, and biotechnology domain to present a logical analysis. To perform the analysis, it uses various software tools, which are specifically designed to generate a biology analysis termed as bioinformatics software. Today, these tools are being used for creating predictive modeling and expression analysis of various genes and phenotypes. Adoption of bioinformatics software tools has significantly reduced the technical burden, introduced accuracy, and enabled efficiency in the way scientific research is conducted.

The global Bioinformatics Software market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Cloud-based accounting for % of the Bioinformatics Software global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Medical Bioinformatics segment is altered to an % CAGR throughout this forecast period.

China Bioinformatics Software market size is valued at US$ million in 2021, while the North America and Europe Bioinformatics Software are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Bioinformatics Software landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bioinformatics Software market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bioinformatics Software market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bioinformatics Software market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bioinformatics Software market.

Bioinformatics Software market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Bioinformatics Software market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

By Type

• Cloud-based
• On-premise

By Application

• Medical Bioinformatics
• Animal Bioinformatics
• Agriculture Bioinformatics
• Academics and Microbial Genome

By Company

• SmartGene Services SARL
• BIOVIA (formerly Accelrys Inc)
• Affymetrix, Inc
• Agilent Technologies
• Biobase GmbH (QIAGEN)
• CLC bio
• DNASTAR, Inc
• PerkinElmer, Inc
• Illumina, Inc (Genologics)
• Genedata AG
• Genomatix Software
• Molecular Networks GmbH

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA